In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
Wolfgang Pernice hunts for the gene that caused his neuromuscular disorder and hopes it will help lead to better treatments for others with Charcot Marie Tooth Disease.
Columbia research finds that people with schizophrenia who have difficulty hearing subtle changes in pitch may be helped with auditory training and a drug targeting NMDA receptors.
